Novel modified frailty index predicts completion of adjuvant chemotherapy in resectable pancreatic cancer in a dual center study
Abstract This study demonstrates that the modified frailty index-6 (mFI-6) is a useful tool for predicting the completion of S-1 adjuvant chemotherapy (AC) and associated adverse events (AEs) in patients with pancreatic cancer (PC). mFI-6 is an index that incorporates serum albumin levels into the e...
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-05-01
|
| Series: | Scientific Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1038/s41598-025-02365-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!